Medicon Village
Scheelevägen 8
Lund 223 63
Sweden
46 4 62 75 60 00
https://www.immunovia.com
Settore/i:
Settore:
Impiegati a tempo pieno: 11
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Jeff Borcherding | Global Chief Executive Officer & President | N/D | N/D | 1973 |
Ms. Karin Almqvist Liwendahl | Chief Financial Officer | N/D | N/D | 1962 |
Dr. Karl M. Stone | Chief Operating Officer | N/D | N/D | 1963 |
Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs | N/D | N/D | N/D |
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
L'ISS Governance QualityScore di Immunovia AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.